Cargando…

Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma

BACKGROUND: Aberrant activities of Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signalling pathways have been implicated in the development and spread of various cancer entities, among them colorectal carcinoma (CRC). Transcription factors STAT3 and STAT1, both downstre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordziel, C, Bratsch, J, Moriggl, R, Knösel, T, Friedrich, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708576/ https://www.ncbi.nlm.nih.gov/pubmed/23756862 http://dx.doi.org/10.1038/bjc.2013.274

Ejemplares similares

The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth
por: Nivarthi, Harini, et al.
Publicado: (2016)

Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth
por: Nivarthi, Harini, et al.
Publicado: (2018)

Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells
por: Okamoto, W, et al.
Publicado: (2011)

DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer
por: Cui, T, et al.
Publicado: (2011)

Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer
por: Hiraoka, N, et al.
Publicado: (2015)

Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphoma
por: Nelson, Lilli S, et al.
Publicado: (2015)

Concurrent infiltration by CD8(+) T cells and CD4(+) T cells is a favourable prognostic factor in non-small-cell lung carcinoma
por: Hiraoka, K, et al.
Publicado: (2006)

Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer
por: Chen, L, et al.
Publicado: (2014)

Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients
por: Zugna, D, et al.
Publicado: (2018)

Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
por: Colomiere, M, et al.
Publicado: (2009)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010)

MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis
por: Wu, W, et al.
Publicado: (2013)

Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer
por: Pfeiffer, M, et al.
Publicado: (2009)

Securin promotes the identification of favourable outcome in invasive breast cancer
por: Talvinen, K, et al.
Publicado: (2009)

The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer
por: Hettiaratchi, A, et al.
Publicado: (2007)

IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling
por: Fukui, H, et al.
Publicado: (2014)

STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells
por: Lin, H-Y, et al.
Publicado: (2013)

Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer
por: Talvinen, K, et al.
Publicado: (2008)

Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer
por: Tam, L, et al.
Publicado: (2007)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival
por: Korkolopoulou, P, et al.
Publicado: (2013)

NT5E CpG island methylation is a favourable breast cancer biomarker
por: Lo Nigro, C, et al.
Publicado: (2012)

Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive
por: O'Toole, A, et al.
Publicado: (2014)

The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
por: Eklöf, V, et al.
Publicado: (2013)

Correlation of malignancy parameters in colorectal carcinoma with up- and downstream signalling partners of STAT3
por: Müller, A, et al.
Publicado: (2009)

Disseminated tumour cells as a prognostic biomarker in colorectal cancer
por: Flatmark, K, et al.
Publicado: (2011)

Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer
por: Baba, Y, et al.
Publicado: (2010)

High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia
por: Song, J H, et al.
Publicado: (2012)

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
por: Ozawa, M, et al.
Publicado: (2014)

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
por: Deb, S, et al.
Publicado: (2014)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Expression and prognostic value of transcription factor PROX1 in colorectal cancer
por: Skog, M, et al.
Publicado: (2011)

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
por: Yokota, T, et al.
Publicado: (2011)

Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
por: Kinoshita, A, et al.
Publicado: (2012)

ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels
por: Rondeau, S, et al.
Publicado: (2015)

Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma
por: Kontos, C K, et al.
Publicado: (2010)

Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia
por: Malesci, A, et al.
Publicado: (2014)

The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues
por: Ling, A, et al.
Publicado: (2014)

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)

HER2/neu testing in primary colorectal carcinoma
por: Ingold Heppner, B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7mk8jchmtbco608k0hqf559qpi